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Background
Mammalian cells, when cultivated in-vitro, are character-
ised by an inefficient glucose metabolism, which leads to
the production of lactic acid. Specific glucose uptake rates
and corresponding lactate production rates are dependent
on the cell line as well as on glucose concentration and
growth rate. To ensure sufficient supply of energy, cells
metabolise glutamine, which improves viability and
growth rates, but results in the release of ammonium into
the medium. High ammonium concentrations, however,
have been shown to impair product glycosylation. As the
mitochondrial membrane potential was shown to corre-
late to cell specific glucose uptake rates, Rhodamine 123,
a lipophilic cationic dye was used for cell sorting. Two
recombinant CHO cell lines with known differences in
lactic acid production rate were used as model cell lines
and subclones obtained by sorting for low and high mito-
chondrial membrane potential, respectively.
Results
The two cell lines C2F5 and C2G12, which both produce
a human monoclonal antibody and which were obtained
by a similar transfection and amplification protocol, differ
in their specific glucose uptake and lactate production
rate, as well as in their growth rates and maximum cell
counts. To isolate cells with an altered energy metabolism,
C2G12 cells were stained with Rh123 and sorted both for
a lower and a higher mitochondrial membrane potential
into 96 well plates. Batch cultures in Spinner bottles were
run of the best subclone of each sort.
Conclusion
Using sorting protocol based on a simple staining method
for mitochondrial membrane potential we were able to
isolate subclones from an established monoclonal anti-
body production cell line with significantly altered physi-
ological properties. The subclone sorted for lower
mitochondrial membrane potential had a faster growth
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Table 1: Numbers in brackets are percent of the corresponding value of the parental cell line
C2F5 C2G12 C2G12 low C2G12 high
Inoculation cell concentration [cells/ml] 0,2 × 106 0,2 × 106 0,2 × 106 0,2 × 106
Cell count after 4 days [cells/ml] 2,0 × 106 0,8 × 106 1,4 × 106 (170) 0,5 × 106 (61)
Specific growth rate [μ/day] 0,61 0,39 0,51 (131) 0,26 (67)
Specific Glucose uptake [pg/cell/day] 525 900 660 (73) 1170 (130)
Specific Glutamine uptake [pg/cell/day] 130 185 165 (88) 245 (132)
Specific Lactate production [pg/cell/day] 505 700 420 (60) 1075 (154)
Specific mAb production [pg/cell/day] 6,3 3,7 7,3 (195) 4,4 (118)
Rh123 fluorescence at 2 g/l glucose [rel.U] 300 455 360 (80) 510 (112)Page 1 of 2
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rate, attained higher final cell concentrations in batch cul-
tures, had lower glucose and glutamine uptake and lactate
production rates as well as a higher specific production
rate. The subclone sorted for high mitochondrial mem-
brane potential on the other hand had a lower growth rate
and final cell count, increased glucose and glutamine con-
sumption and lactate production rates. These subclones
can now be used for genomic or proteomic analysis of
properties that characterise a cell line with efficient or
inefficient metabolism. In addition, the method described
is a valuable tool for cell line development and optimisa-
tion, offering the possibility to isolate subclones with
both superior and inferior properties. Future cell line
development programs can now be extended from merely
looking for a cell line with a high specific production rate,
to one, which in addition has optimised metabolic prop-
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